Cite
Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer
MLA
Ouathek Ouerfelli, et al. “Optimized Pretargeting of [89Zr]Zr-DO3A-Proteus Radiohapten in Rodent Models of Human Colorectal Cancer.” Nuclear Medicine and Biology, May 2021, pp. S3–4. EBSCOhost, https://doi.org/10.1016/s0969-8051(21)00273-0.
APA
Ouathek Ouerfelli, Hong-fen Guo, Darren R. Veach, Nai-Kong V. Cheung, Shin Seo, Joseph R. Osborne, Valerie A. Longo, Hong Xu, Daniela Burnes Vargas, Sarah M. Cheal, Alexandre Le Roux, Steven M. Larson, & Guangbin Yang. (2021). Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer. Nuclear Medicine and Biology, S3–S4. https://doi.org/10.1016/s0969-8051(21)00273-0
Chicago
Ouathek Ouerfelli, Hong-fen Guo, Darren R. Veach, Nai-Kong V. Cheung, Shin Seo, Joseph R. Osborne, Valerie A. Longo, et al. 2021. “Optimized Pretargeting of [89Zr]Zr-DO3A-Proteus Radiohapten in Rodent Models of Human Colorectal Cancer.” Nuclear Medicine and Biology, May, S3–4. doi:10.1016/s0969-8051(21)00273-0.